ENLV Stock Analysis: Buy, Sell, or Hold?
ENLV - Enlivex Therapeutics Ltd. Ordinary Shares
$1.47
-0.03 (-2.00%)
▼
5d:
-6.96%
30d:
-66.28%
90d:
+104.11%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 04, 2026
10d
Get Alerted When ENLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ENLV is currently trading at $1.47, which is considered slightly low relative to its 30-day fair value range of $1.44 to $3.90.
Technical Outlook: Technically, ENLV is in a uptrend. Immediate support is located at $1.39, while resistance sits at $2.18.
Market Sentiment: ENLV scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $80.00 (+5342.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENLV is in a uptrend. Immediate support is located at $1.39, while resistance sits at $2.18.
Market Sentiment: ENLV scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $80.00 (+5342.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.44 -
$3.90
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 5342.2% below Wall St target ($80.00)
- CAUTION: Bottoming setup, but lagging the sector by 65% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-7.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.44 -
$3.90
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.39
Resistance Level
$2.18
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.00
Wall Street Target
$80.00
(+5342.2%)
Share & Embed Analysis
Last updated: August 24, 2026 2:19 AM ET
Data refreshes hourly during market hours. Next update: 3:19 AM
Data refreshes hourly during market hours. Next update: 3:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENLV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
